Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-04

Clinical Trial Update: The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on long-term effects of Alfuzosin (Xatral XL) in men with benign prostatic hyperplasia and lower urinary tract symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfuzosin (alfuzosin)

Snippet

Sponsor: Asan Medical Center | Conditions: BPH | Phase 4 | Status: COMPLETED | Results posted: 2014-03-04